Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies
Zamboni, W C, Strychor, S, Maruca, L, Ramalingam, S, Zamboni, B A, Wu, H, Friedland, D M, Edwards, R P, Stoller, R G, Belani, C P, Ramanathan, R K
Published in Clinical pharmacology and therapeutics (01.11.2009)
Published in Clinical pharmacology and therapeutics (01.11.2009)
Get more information
Journal Article
A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations
Villaruz, L.C., Wang, X., Bertino, E.M., Gu, L., Antonia, S.J., Burns, T.F., Clarke, J., Crawford, J., Evans, T.L., Friedland, D.M., Otterson, G.A., Ready, N.E., Wozniak, A.J., Stinchcombe, T.E.
Published in ESMO open (01.04.2023)
Published in ESMO open (01.04.2023)
Get full text
Journal Article
Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors
Kovatich, Albert, Friedland, David M., Druck, Teresa, Hadaczek, Piotr, Huebner, Kay, Comis, Robert L., Hauck, Walter, McCue, Peter A.
Published in Cancer (15.09.1998)
Published in Cancer (15.09.1998)
Get full text
Journal Article
The role of oral etoposide in non-small cell lung cancer
Get full text
Conference Proceeding
Journal Article
What should be the routine follow-up after definitive therapy of localized lung cancer?
Pieters, R S, Krutchik, A N, Kane, G C, Friedland, D M
Published in Seminars in oncology (01.08.1996)
Get more information
Published in Seminars in oncology (01.08.1996)
Journal Article
Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced solid tumors
Wu, H., Ramanathan, R. K., Srychor, S., Zamboni, B. A., Ramalingam, S., Edwards, R. P., Friedland, D. M., Stoller, R. G., Belani, C. P., Zamboni, W. C.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Bevacizumab plus irinotecan therapy in relapsed, heavily pre-treated malignant glioma: A case series
Friedland, D. M., Ali, S. A., Ahmad, A., Rahman, M., Bejjani, G., Braffet, M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Docetaxel and imatinib every 21 days for castration resistant prostate cancer: A phase II trial
Gillison, T. L., Appleman, L. J., Friedland, D. M., Evans, T. L., Lara, P. N., Gooding, W. E., Lenzner, D. E., Strausser, H. M., Gingrich, J. R., Chatta, G. S.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Age and body composition related-effects on the pharmacokinetic disposition of STEALTH liposomal CKD- 602 (S-CKD602) in patients with advanced solid tumors
Zamboni, W., Maruca, L. J., Strychor, S., Zamboni, B. A., Ramalingam, S., Edwards, R. P., Friedland, D. M., Stoller, R. G., Belani, C. P., Ramanathan, R. K.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
A phase II trial of oxaliplatin and docetaxel in patients with androgen independent prostate cancer (AIPC) who have progressed to two prior regimens of chemotherapy
Feinstein, T., Appleman, L. J., Friedland, D. M., Jacobs, S. A., Ferri, W. A., Earle, M. F., Hyoung, K. D., Strausser, H., Corgnati, S., Chatta, G. S.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article